Loading...
AbbVie Community
NYSE:ABBV Community- 1 Narratives written by author
- 1 Comments on narratives written by author
- 512 Fair Values set on narratives written by author
Community Investing Ideas
Continued Expansion in Neuroscience and Immunology Will Drive Leadership Beyond 2025
Key Takeaways Strong performance in immunology and neuroscience, supported by new product launches and expanding indications, helps offset losses from older drugs facing competition. Strategic pipeline development, international growth, and operational efficiency position the company to sustain profitability and adapt to evolving industry trends.Read more
2users have liked this narrative
1users have commented on this narrative
257users have followed this narrative
AN
US$241.29
2.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
8.1% p.a.
Profit Margin
29.6%
Future PE
23.61x
Share price in 2028
US$297.83
